vs
德康医疗（DXCM）与凯悦酒店集团（H）财务数据对比。点击上方公司名可切换其他公司
凯悦酒店集团的季度营收约是德康医疗的1.4倍（$1.8B vs $1.3B），德康医疗净利率更高（21.2% vs -1.1%，领先22.3%），德康医疗同比增速更快（21.6% vs 11.7%），过去两年德康医疗的营收复合增速更高（12.0% vs 2.2%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
凯悦酒店集团是来自美国的跨国酒店管理企业，总部位于芝加哥河畔广场区域，由普利兹克家族运营管理。集团主营高端及商务酒店、度假村、度假物业的管理与特许经营业务，目前在全球69个国家拥有逾1350家酒店及一价全包物业，覆盖六大洲。
DXCM vs H — 直观对比
营收规模更大
H
是对方的1.4倍
$1.3B
营收增速更快
DXCM
高出9.9%
11.7%
净利率更高
DXCM
高出22.3%
-1.1%
两年增速更快
DXCM
近两年复合增速
2.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $1.8B |
| 净利润 | $267.3M | $-20.0M |
| 毛利率 | 62.9% | — |
| 营业利润率 | 25.6% | 0.4% |
| 净利率 | 21.2% | -1.1% |
| 营收同比 | 21.6% | 11.7% |
| 净利润同比 | 153.6% | 64.3% |
| 每股收益（稀释后） | $0.67 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMH
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.8B | ||
| Q3 25 | $1.2B | $1.8B | ||
| Q2 25 | $1.2B | $1.8B | ||
| Q1 25 | $1.0B | $1.7B | ||
| Q4 24 | $1.1B | $1.6B | ||
| Q3 24 | $994.2M | $1.6B | ||
| Q2 24 | $1.0B | $1.7B |
净利润DXCMH
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $-20.0M | ||
| Q3 25 | $283.8M | $-49.0M | ||
| Q2 25 | $179.8M | $-3.0M | ||
| Q1 25 | $105.4M | $20.0M | ||
| Q4 24 | $151.7M | $-56.0M | ||
| Q3 24 | $134.6M | $471.0M | ||
| Q2 24 | $143.5M | $359.0M |
毛利率DXCMH
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
营业利润率DXCMH
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 0.4% | ||
| Q3 25 | 20.1% | -1.0% | ||
| Q2 25 | 18.4% | 2.1% | ||
| Q1 25 | 12.9% | 3.0% | ||
| Q4 24 | 17.0% | -3.0% | ||
| Q3 24 | 15.3% | 37.3% | ||
| Q2 24 | 15.7% | 27.1% |
净利率DXCMH
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | -1.1% | ||
| Q3 25 | 23.5% | -2.7% | ||
| Q2 25 | 15.5% | -0.2% | ||
| Q1 25 | 10.2% | 1.2% | ||
| Q4 24 | 13.6% | -3.5% | ||
| Q3 24 | 13.5% | 28.9% | ||
| Q2 24 | 14.3% | 21.1% |
每股收益（稀释后）DXCMH
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $-0.20 | ||
| Q3 25 | $0.70 | $-0.51 | ||
| Q2 25 | $0.45 | $-0.03 | ||
| Q1 25 | $0.27 | $0.19 | ||
| Q4 24 | $0.37 | $-0.37 | ||
| Q3 24 | $0.34 | $4.63 | ||
| Q2 24 | $0.35 | $3.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $813.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $3.3B |
| 总资产 | $6.3B | $14.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DXCMH
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $813.0M | ||
| Q3 25 | $1.8B | $749.0M | ||
| Q2 25 | $1.2B | $912.0M | ||
| Q1 25 | $904.9M | $1.8B | ||
| Q4 24 | $606.1M | $1.4B | ||
| Q3 24 | $621.2M | $1.1B | ||
| Q2 24 | $939.2M | $2.0B |
总债务DXCMH
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $6.0B | ||
| Q2 25 | — | $6.0B | ||
| Q1 25 | — | $4.3B | ||
| Q4 24 | — | $3.8B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.9B |
股东权益DXCMH
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $3.3B | ||
| Q3 25 | $2.7B | $3.5B | ||
| Q2 25 | $2.6B | $3.6B | ||
| Q1 25 | $2.3B | $3.5B | ||
| Q4 24 | $2.1B | $3.5B | ||
| Q3 24 | $2.0B | $3.7B | ||
| Q2 24 | $2.4B | $3.9B |
总资产DXCMH
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $14.0B | ||
| Q3 25 | $7.5B | $15.7B | ||
| Q2 25 | $7.3B | $15.9B | ||
| Q1 25 | $6.8B | $14.0B | ||
| Q4 24 | $6.5B | $13.3B | ||
| Q3 24 | $6.4B | $11.9B | ||
| Q2 24 | $6.8B | $12.8B |
负债/权益比DXCMH
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.73× | ||
| Q2 25 | — | 1.69× | ||
| Q1 25 | — | 1.25× | ||
| Q4 24 | — | 1.07× | ||
| Q3 24 | — | 0.85× | ||
| Q2 24 | — | 1.01× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $313.0M |
| 自由现金流经营现金流 - 资本支出 | — | $236.0M |
| 自由现金流率自由现金流/营收 | — | 13.2% |
| 资本支出强度资本支出/营收 | — | 4.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $159.0M |
8季度趋势，按日历期对齐
经营现金流DXCMH
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $313.0M | ||
| Q3 25 | $659.9M | $-20.0M | ||
| Q2 25 | $303.0M | $-67.0M | ||
| Q1 25 | $183.8M | $153.0M | ||
| Q4 24 | $301.4M | $235.0M | ||
| Q3 24 | $199.5M | $-21.0M | ||
| Q2 24 | $279.4M | $177.0M |
自由现金流DXCMH
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $236.0M | ||
| Q3 25 | $579.4M | $-89.0M | ||
| Q2 25 | $208.9M | $-111.0M | ||
| Q1 25 | $96.8M | $123.0M | ||
| Q4 24 | $176.8M | $184.0M | ||
| Q3 24 | $88.3M | $-64.0M | ||
| Q2 24 | $213.3M | $135.0M |
自由现金流率DXCMH
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 13.2% | ||
| Q3 25 | 47.9% | -5.0% | ||
| Q2 25 | 18.1% | -6.1% | ||
| Q1 25 | 9.3% | 7.2% | ||
| Q4 24 | 15.9% | 11.5% | ||
| Q3 24 | 8.9% | -3.9% | ||
| Q2 24 | 21.2% | 7.9% |
资本支出强度DXCMH
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 4.3% | ||
| Q3 25 | 6.7% | 3.9% | ||
| Q2 25 | 8.1% | 2.4% | ||
| Q1 25 | 8.4% | 1.7% | ||
| Q4 24 | 11.2% | 3.2% | ||
| Q3 24 | 11.2% | 2.6% | ||
| Q2 24 | 6.6% | 2.5% |
现金转化率DXCMH
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | — | ||
| Q3 25 | 2.33× | — | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 1.74× | 7.65× | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | -0.04× | ||
| Q2 24 | 1.95× | 0.49× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXCM
暂无分部数据
H
| Other | $627.0M | 35% |
| Rooms Revenue | $326.0M | 18% |
| Net Fees | $290.0M | 16% |
| Distribution Segment | $177.0M | 10% |
| Franchise And Other Fees | $114.0M | 6% |
| Base Management Fees | $112.0M | 6% |
| Incentive Management Fees | $81.0M | 5% |
| Other Owned And Leased Hotel Revenue | $41.0M | 2% |
| Contra Revenue | $17.0M | 1% |
| Other Revenues | $4.0M | 0% |
